litvin ophthalmic surgery limited
litvin ophthalmic surgery limited Company Information
Company Number
07368158
Next Accounts
Jun 2025
Shareholders
norman philip litvin
leone badia litvin
View AllGroup Structure
View All
Industry
Other human health activities
Registered Address
16 primley park avenue, alwoodley, leeds, west yorkshire, LS17 7JA
Website
-litvin ophthalmic surgery limited Estimated Valuation
Pomanda estimates the enterprise value of LITVIN OPHTHALMIC SURGERY LIMITED at £495.6k based on a Turnover of £1.1m and 0.43x industry multiple (adjusted for size and gross margin).
litvin ophthalmic surgery limited Estimated Valuation
Pomanda estimates the enterprise value of LITVIN OPHTHALMIC SURGERY LIMITED at £601.8k based on an EBITDA of £187.6k and a 3.21x industry multiple (adjusted for size and gross margin).
litvin ophthalmic surgery limited Estimated Valuation
Pomanda estimates the enterprise value of LITVIN OPHTHALMIC SURGERY LIMITED at £999k based on Net Assets of £406.6k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Litvin Ophthalmic Surgery Limited Overview
Litvin Ophthalmic Surgery Limited is a live company located in leeds, LS17 7JA with a Companies House number of 07368158. It operates in the other human health activities sector, SIC Code 86900. Founded in September 2010, it's largest shareholder is norman philip litvin with a 53% stake. Litvin Ophthalmic Surgery Limited is a established, small sized company, Pomanda has estimated its turnover at £1.1m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Litvin Ophthalmic Surgery Limited Health Check
Pomanda's financial health check has awarded Litvin Ophthalmic Surgery Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
3 Weak
Size
annual sales of £1.1m, make it larger than the average company (£665.8k)
- Litvin Ophthalmic Surgery Limited
£665.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 43%, show it is growing at a faster rate (5.9%)
- Litvin Ophthalmic Surgery Limited
5.9% - Industry AVG
Production
with a gross margin of 21.8%, this company has a higher cost of product (38.2%)
- Litvin Ophthalmic Surgery Limited
38.2% - Industry AVG
Profitability
an operating margin of 16.5% make it more profitable than the average company (5.6%)
- Litvin Ophthalmic Surgery Limited
5.6% - Industry AVG
Employees
with 2 employees, this is below the industry average (17)
2 - Litvin Ophthalmic Surgery Limited
17 - Industry AVG
Pay Structure
on an average salary of £25.8k, the company has an equivalent pay structure (£25.8k)
- Litvin Ophthalmic Surgery Limited
£25.8k - Industry AVG
Efficiency
resulting in sales per employee of £569.9k, this is more efficient (£48k)
- Litvin Ophthalmic Surgery Limited
£48k - Industry AVG
Debtor Days
it gets paid by customers after 149 days, this is later than average (23 days)
- Litvin Ophthalmic Surgery Limited
23 days - Industry AVG
Creditor Days
its suppliers are paid after 27 days, this is slower than average (18 days)
- Litvin Ophthalmic Surgery Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Litvin Ophthalmic Surgery Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Litvin Ophthalmic Surgery Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 14.8%, this is a lower level of debt than the average (26.6%)
14.8% - Litvin Ophthalmic Surgery Limited
26.6% - Industry AVG
LITVIN OPHTHALMIC SURGERY LIMITED financials
Litvin Ophthalmic Surgery Limited's latest turnover from September 2023 is estimated at £1.1 million and the company has net assets of £406.6 thousand. According to their latest financial statements, Litvin Ophthalmic Surgery Limited has 2 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | |||||||||||||
| Gross Profit | |||||||||||||
| Admin Expenses | |||||||||||||
| Operating Profit | |||||||||||||
| Interest Payable | |||||||||||||
| Interest Receivable | |||||||||||||
| Pre-Tax Profit | |||||||||||||
| Tax | |||||||||||||
| Profit After Tax | |||||||||||||
| Dividends Paid | |||||||||||||
| Retained Profit | |||||||||||||
| Employee Costs | |||||||||||||
| Number Of Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 9,435 | 580 | 540 | 708 | 341 | 307 | 421 | 562 | 288 | 384 | 511 | 682 | 509 |
| Intangible Assets | |||||||||||||
| Investments & Other | |||||||||||||
| Debtors (Due After 1 year) | |||||||||||||
| Total Fixed Assets | 9,435 | 580 | 540 | 708 | 341 | 307 | 421 | 562 | 288 | 384 | 511 | 682 | 509 |
| Stock & work in progress | |||||||||||||
| Trade Debtors | 467,179 | 314,930 | 180,533 | 139,737 | 169,171 | 124,241 | 92,057 | 19,961 | 13,080 | 11,323 | 15,009 | 16,335 | 14,416 |
| Group Debtors | |||||||||||||
| Misc Debtors | 500 | ||||||||||||
| Cash | 55,141 | 79,832 | 97,967 | 156,030 | 168,666 | 83,970 | |||||||
| misc current assets | |||||||||||||
| total current assets | 467,679 | 314,930 | 180,533 | 139,737 | 169,171 | 124,241 | 92,057 | 75,102 | 92,912 | 109,290 | 171,039 | 185,001 | 98,386 |
| total assets | 477,114 | 315,510 | 181,073 | 140,445 | 169,512 | 124,548 | 92,478 | 75,664 | 93,200 | 109,674 | 171,550 | 185,683 | 98,895 |
| Bank overdraft | |||||||||||||
| Bank loan | |||||||||||||
| Trade Creditors | 67,219 | 46,523 | 29,514 | 21,575 | 34,972 | 33,757 | 25,899 | 28,684 | 29,811 | 48,186 | 44,441 | 52,569 | 35,001 |
| Group/Directors Accounts | |||||||||||||
| other short term finances | |||||||||||||
| hp & lease commitments | |||||||||||||
| other current liabilities | |||||||||||||
| total current liabilities | 67,219 | 46,523 | 29,514 | 21,575 | 34,972 | 33,757 | 25,899 | 28,684 | 29,811 | 48,186 | 44,441 | 52,569 | 35,001 |
| loans | |||||||||||||
| hp & lease commitments | |||||||||||||
| Accruals and Deferred Income | 3,300 | 3,120 | 2,592 | 2,520 | 2,640 | 2,640 | 2,640 | ||||||
| other liabilities | |||||||||||||
| provisions | 96 | 57 | 77 | 102 | 136 | 102 | |||||||
| total long term liabilities | 3,300 | 3,120 | 2,592 | 2,520 | 2,640 | 2,640 | 2,640 | 96 | 57 | 77 | 102 | 136 | 102 |
| total liabilities | 70,519 | 49,643 | 32,106 | 24,095 | 37,612 | 36,397 | 28,539 | 28,780 | 29,868 | 48,263 | 44,543 | 52,705 | 35,103 |
| net assets | 406,595 | 265,867 | 148,967 | 116,350 | 131,900 | 88,151 | 63,939 | 46,884 | 63,332 | 61,411 | 127,007 | 132,978 | 63,792 |
| total shareholders funds | 406,595 | 265,867 | 148,967 | 116,350 | 131,900 | 88,151 | 63,939 | 46,884 | 63,332 | 61,411 | 127,007 | 132,978 | 63,792 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | Sep 2013 | Sep 2012 | Sep 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | |||||||||||||
| Depreciation | 188 | 96 | 127 | 171 | 227 | 87 | |||||||
| Amortisation | |||||||||||||
| Tax | |||||||||||||
| Stock | |||||||||||||
| Debtors | 152,749 | 134,397 | 40,796 | -29,434 | 44,930 | 32,184 | 72,096 | 6,881 | 1,757 | -3,686 | -1,326 | 1,919 | 14,416 |
| Creditors | 20,696 | 17,009 | 7,939 | -13,397 | 1,215 | 7,858 | -2,785 | -1,127 | -18,375 | 3,745 | -8,128 | 17,568 | 35,001 |
| Accruals and Deferred Income | 180 | 528 | 72 | -120 | 2,640 | ||||||||
| Deferred Taxes & Provisions | -96 | 39 | -20 | -25 | -34 | 34 | 102 | ||||||
| Cash flow from operations | |||||||||||||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | |||||||||||||
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | |||||||||||||
| Group/Directors Accounts | |||||||||||||
| Other Short Term Loans | |||||||||||||
| Long term loans | |||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||
| other long term liabilities | |||||||||||||
| share issue | |||||||||||||
| interest | |||||||||||||
| cash flow from financing | |||||||||||||
| cash and cash equivalents | |||||||||||||
| cash | -55,141 | -24,691 | -18,135 | -58,063 | -12,636 | 84,696 | 83,970 | ||||||
| overdraft | |||||||||||||
| change in cash | -55,141 | -24,691 | -18,135 | -58,063 | -12,636 | 84,696 | 83,970 |
litvin ophthalmic surgery limited Credit Report and Business Information
Litvin Ophthalmic Surgery Limited Competitor Analysis
Perform a competitor analysis for litvin ophthalmic surgery limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in LS17 area or any other competitors across 12 key performance metrics.
litvin ophthalmic surgery limited Ownership
LITVIN OPHTHALMIC SURGERY LIMITED group structure
Litvin Ophthalmic Surgery Limited has no subsidiary companies.
Ultimate parent company
LITVIN OPHTHALMIC SURGERY LIMITED
07368158
litvin ophthalmic surgery limited directors
Litvin Ophthalmic Surgery Limited currently has 2 directors. The longest serving directors include Dr Norman Litvin (Sep 2010) and Mrs Leone Litvin (Sep 2010).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Norman Litvin | United Kingdom | 57 years | Sep 2010 | - | Director |
| Mrs Leone Litvin | United Kingdom | 58 years | Sep 2010 | - | Director |
P&L
September 2023turnover
1.1m
+53%
operating profit
187.6k
0%
gross margin
21.8%
+1.03%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
406.6k
+0.53%
total assets
477.1k
+0.51%
cash
0
0%
net assets
Total assets minus all liabilities
litvin ophthalmic surgery limited company details
company number
07368158
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
September 2010
age
15
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
16 primley park avenue, alwoodley, leeds, west yorkshire, LS17 7JA
Bank
-
Legal Advisor
-
litvin ophthalmic surgery limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to litvin ophthalmic surgery limited.
litvin ophthalmic surgery limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for LITVIN OPHTHALMIC SURGERY LIMITED. This can take several minutes, an email will notify you when this has completed.
litvin ophthalmic surgery limited Companies House Filings - See Documents
| date | description | view/download |
|---|
